Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial

[1]  K. Anstrom,et al.  Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. , 2000, Journal of the American College of Cardiology.

[2]  H. Rakowski,et al.  Preventing perioperative stroke: look, but don't touch! , 1999, American heart journal.

[3]  T. Guarnieri,et al.  Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. , 1999, Journal of the American College of Cardiology.

[4]  W. O’Neill,et al.  Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. , 1999, American heart journal.

[5]  M. Chow,et al.  Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold. , 1998, Journal of the American College of Cardiology.

[6]  L. Toivonen,et al.  Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. , 1998, Journal of cardiovascular pharmacology.

[7]  F. Morady,et al.  Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery , 1997 .

[8]  Mark F. Newman,et al.  Adverse Cerebral Outcomes after Coronary Bypass Surgery , 1996 .

[9]  L. Smith,et al.  Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. , 1996, Circulation.

[10]  W. Browner,et al.  Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. , 1996, JAMA.

[11]  A. Bollinger,et al.  Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich study). , 1996, Circulation.

[12]  A M Tonkin,et al.  Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. , 1995, The Annals of thoracic surgery.

[13]  C. Peniston,et al.  Risk Factors for Stroke Following Coronary Bypass Surgery , 1995, Journal of cardiac surgery.

[14]  L. Creswell,et al.  Hazards of postoperative atrial arrhythmias , 1993 .

[15]  S. Westaby,et al.  Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. , 1993, British heart journal.

[16]  J. Reed,et al.  Risk factors for stroke after coronary artery bypass. , 1992, The Journal of thoracic and cardiovascular surgery.

[17]  R. Marinchak,et al.  Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. , 1992, The American journal of cardiology.

[18]  J. Tijssen,et al.  Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. , 1991, The American journal of cardiology.

[19]  E. Antman,et al.  Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. , 1991, Circulation.

[20]  M. Metzdorff,et al.  Coronary artery bypass grafting in elderly patients. Comparative results in a consecutive series of 469 patients older than 75 years. , 1991, The Journal of thoracic and cardiovascular surgery.

[21]  S. Hohnloser,et al.  Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. , 1991, American heart journal.

[22]  J A Burkholder,et al.  Risk factors for atrial fibrillation after coronary artery bypass grafting. , 1990, The American journal of cardiology.

[23]  R. M. Tjon Joe Gin,et al.  Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. , 1990, The Journal of thoracic and cardiovascular surgery.

[24]  P. Harris,et al.  The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. , 1990, The Journal of thoracic and cardiovascular surgery.

[25]  J J Heger,et al.  Clinical features of amiodarone-induced pulmonary toxicity. , 1990, Circulation.

[26]  B. Buxton,et al.  Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? , 1989, The Journal of thoracic and cardiovascular surgery.

[27]  M. Lauer,et al.  Atrial fibrillation following coronary artery bypass surgery. , 1989, Progress in cardiovascular diseases.

[28]  K. Nademanee,et al.  The historical development, cellular electrophysiology and pharmacology of amiodarone. , 1989, Progress in cardiovascular diseases.

[29]  G. Taylor,et al.  Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. , 1987, The American journal of cardiology.

[30]  M. Taams,et al.  Prevention and Treatment of Supraventricular Tachycardia Shortly After Coronary Artery Bypass Grafting: A Randomized Open Trial , 1986, Angiology.

[31]  E. Prystowsky,et al.  Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. , 1984, Journal of the American College of Cardiology.